« Back
Home /
Polyclonal Antibody to Dyskerin (DKC)

Polyclonal Antibody to Dyskerin (DKC)

Manufacturer	Cloud-Clone
Category	Neuroscience Molecular Targets for Neuroscience Infectious Diseases Viral Infections Coronavirus (COVID-19) Antibodies Immunohistochemistry Immunoprecipitation Western Blot Immunocytochemistry Primary Antibodies
Type	Antibody Polyclonal
Specific against	Human
Applications	WB, IP, IHC, ICC
Amount	20ul
Host	Rabbit
Item no.	PAC446Hu01-20ul
Targets	SRCIN1, DKC1
eClass 6.1	32160702
eClass 9.0	32160702
Available
Alias	DKC1, NAP57, NOLA4, NAP57, Dyskeratosis Congenita 1, H/ACA Ribonucleoprotein Complex Subunit 4, Nopp140-associated protein of 57 kDa, Nucleolar protein family A member 4
Quantity options
Alternative Names	DKC1, NAP57, NOLA4, NAP57, Dyskeratosis Congenita 1, H/ACA Ribonucleoprotein Complex Subunit 4, Nopp140-associated protein of 57 kDa, Nucleolar protein family A member 4
Research Area	Immune molecule, Developmental science,
Buffer Formulation	0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Immunogen	RPC446Hu01-Recombinant Dyskerin (DKC)
Usage	Western blotting: 0.5-2ug/mL; 1:250-1000 Immunohistochemistry: 5-20ug/mL; 1:25-100 Immunocytochemistry: 5-20ug/mL; 1:25-100 Optimal working dilutions must be determined by end user.
Traits	Liquid
Purification	Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.